- Zacks Small Cap Research•7 days ago
In early December 2016, Critical Outcome Technologies (COT.V) (COTQF) appointed Alison Silva as the Company’s new Chief Executive Officer (CEO) effective January 1, 2017. Ms. Silva served before the appointment on the Board of Directors and as President. Alison has worked with COT.V in various roles since 2013, during which time she has been integral in shaping the Company’s orphan drug development strategy.
- Marketwired•23 days ago
Critical Outcome Technologies Inc. , a clinical stage biopharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, announced today that Dr. Wayne Danter...
- Marketwired•last monthCritical Outcome Technologies to Be a Panelist and Presenter at Cantech Investment Conference in Toronto
Critical Outcome Technologies Inc. a clinical stage biotechnology company advancing a pipeline of targeted therapies for the treatment of cancer, announced today that it will be a panelist...
COT.V : Summary for CRITICAL OUTCOME TECHNOLOGIES I - Yahoo Finance
Critical Outcome Technologies Inc. (COT.V)
TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||0.55 - 0.57|
|52 Week Range||0.30 - 0.90|
|PE Ratio (TTM)||-12.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|